In a double-blind study with a placebo group, chronic insomniac patients administered with a DSIP analogue experienced a reduction in sleep latency by an average of 22 minutes, suggesting its potential as a therapeutic agent for severe chronic insomnia patients (Anderer & Saletu, 1991)
This formula is sure to be of interest to researchers interested in enhanced injury recovery, as well as addressing symptoms of inflammatory, cardiovascular, and neurological diseases
Please be assured that all RegActiv products will continue to undergo rigorous third-party testing to uphold the highest standards of quality, safety, and efficacy that youve come to expect from us
is Director and D.W
Nutritional interventions can target key pathophysiological mechanisms of endometriosis, such as systemic inflammation, oxidative stress, and hormonal imbalance, offering potential symptom relief and improved clinical outcomes